It has been reported that integrin α3 upregulates the phosphorylation of FAK in hepatocellular carcinoma, indicating that FAK may be the driving force for the oncogenic activity of integrin α3 (12). The gene discussed is PTK2; the disease is hepatocellular carcinoma.